ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Resource utilization and cost of diarrhea-related hospitalizations among cancer patients in Jordan.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDiarrhea is a common complication that can lead to hospitalization in cancer patients. Few studies evaluated its impact on resource utilization and cost. Our objective was to evaluate the resource utilization and costs associated with hospital admission due to diarrhea in cancer patients.
methodsThis was a retrospective study at a comprehensive cancer center in Jordan. We included adult cancer patients with primary admission diagnosis of diarrhea, between January 2022 and December 2023. Patients were identified using the International Classification of Diseases, Tenth Revision. Resources evaluated included hospital length of stay and admission to the intensive care unit (ICU). Costs in US$ were estimated based on reports from the finance department, reflecting the payers' perspective, which provided total admission costs, as well as costs of medications, laboratory tests, and procedures. Descriptive analysis was used to report the results.
resultsDuring the study period, 390 patients were admitted for diarrhea. Mean age was 56 ± 14 (SD) years and 57% were females. Median(IQR) hospital length of stay was 4 (2-7) days, and 34 (9%) patients required ICU admission. The median (IQR) total cost per admission was US$2636 (1441-6132), while median (IQR) cost for ICU admissions was US$10,628(5759-17,235). Laboratory tests had the highest cost, (US$975, 537-1813), followed by medications (US$552, 241-1621) and procedures (US$251, 139-576).
conclusionDiarrhea among cancer patients is associated with resource utilization and costs. Laboratory tests and medications accounted for the highest proportion of the cost. Future studies should identify strategies to prevent such complications and to reduce cost.
Indexed as
Identifiers
40434708What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.